相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study
Jiazi Ren et al.
FRONTIERS IN ONCOLOGY (2021)
Impact of Lymphovascular Invasion in Patients With Stage II Colorectal Cancer: A Propensity Score-matched Study
Masahiro Kataoka et al.
IN VIVO (2021)
Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer
Hai Luo et al.
ONCOLOGY LETTERS (2020)
Rectal Cancer, Version 6.2020 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
A new prognostic and predictive tool for shared decision making in stage III colon cancer
Alberto F. Sobrero et al.
EUROPEAN JOURNAL OF CANCER (2020)
Adjuvant Chemotherapy for Stage II Colon Cancer
Sara Elena Rebuzzi et al.
CANCERS (2020)
Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
Jae-Uk Jeong et al.
RADIATION ONCOLOGY JOURNAL (2019)
Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer
Yusuke Okuda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Current clinical practice of adjuvant chemotherapy for patients with 'high-risk' Stage II colorectal cancer in Japan: a questionnaire survey in the JCOG Study Group
Megumi Ishiguro et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Heterogeneity of Tumor Sizes in Multiple Pulmonary Metastases of Colorectal Cancer as a Prognostic Factor
Tomohiro Maniwa et al.
ANNALS OF THORACIC SURGERY (2017)
High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
Ji Soo Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women
Chi-Jung Huang et al.
MEDICINE (2016)
Tumor size is an independent risk predictor for metachronous colorectal cancer
Takaharu Kato et al.
ONCOTARGET (2016)
Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer
Mohammed A. Aleskandarany et al.
PATHOBIOLOGY (2015)
Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
Camilla Bockelman et al.
ACTA ONCOLOGICA (2015)
The role of adjuvant chemotherapy in stage II colorectal cancer patients
Hung-Hsin Lin et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Labianca et al.
ANNALS OF ONCOLOGY (2013)
Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
Christophe Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Value of Tumor Size as a Prognostic Variable in Colorectal Cancer A Critical Reappraisal
Peter Kornprat et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
Catherine Theriault et al.
GYNECOLOGIC ONCOLOGY (2011)
Challenges in the Management of Stage II Colon Cancer
Efrat Dotan et al.
SEMINARS IN ONCOLOGY (2011)
Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2009)
Identification of patients with high-risk stage II colon cancer for adjuvant therapy
Hak-Mien Quah et al.
DISEASES OF THE COLON & RECTUM (2008)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Richard Gray et al.
LANCET (2007)
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
W. Schippinger et al.
BRITISH JOURNAL OF CANCER (2007)
Adjuvant chemotherapy in colorectal cancer:: A joint analysis of randomised trials by the Nordic gastrointestinal tumour adjuvant therapy group
B Glimelius et al.
ACTA ONCOLOGICA (2005)
Outcome of anterior resection for stage II rectal cancer without radiation: The role of adjuvant chemotherapy
WL Law et al.
DISEASES OF THE COLON & RECTUM (2005)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group
A Figueredo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
CA 125: A clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen
GM Mavligit et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
分享论文
